Mannatech (NASDAQ:MTEX) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Sunday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

MTEX opened at $8.01 on Friday. Mannatech has a 52-week low of $6.75 and a 52-week high of $10.51. The company has a 50 day moving average of $7.74 and a two-hundred day moving average of $7.55. The company has a market cap of $15.10 million, a P/E ratio of -12.71 and a beta of 1.17. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million for the quarter.

Insider Activity

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares in the company, valued at $424,087.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.